3-Nicotinoylpyrazolo[1, 5-a]pyridines were synthesized by the raation of 3-unsubstituted pyrazolo[1, 5-a]pyridines with nicotinoyl chloride hydrochloride. Tetrahydronicotinoyl derivatives were obtained by hydrogenation of the nicotinoyl derivatives. Furthermore, N-substituted derivatives were synthesized by the reaction of the tetrahydronicotinoyl derivatives with alkylating regents or isocyanates. These pyrazolo[1, 5-a]pyridines were tested for inhibitory activity on arachidonic acid induced platelet aggregation in vitro and ex vivo. Some of these compounds showed higher inhibitory activity than aspirin. Among them, 2-methyl-3-(1, 4, 5, 6-tetrahydronicotinoyl)pyrazolo[1, 5-a]pyridine was found to be the most active compound.
3- 未取代的
吡唑并[1, 5-a]
吡啶与
烟酰氯盐酸盐反应合成了 3-烟酰基
吡唑并[1, 5-a]
吡啶。通过对
烟碱酰
氯衍
生物进行氢化,得到了四氢
烟碱酰
氯衍
生物。此外,通过四氢烟酰衍
生物与烷基化调节剂或
异氰酸酯的反应,还合成了 N-取代衍
生物。这些
吡唑并[1, 5-a]
吡啶在体外和体内测试了对
花生四烯酸诱导的血小板聚集的抑制活性。其中一些化合物的抑制活性高于
阿司匹林。其中,2-甲基-3-(1,4,5,6-四氢烟酰)
吡唑并[1,5-a]
吡啶被认为是活性最强的化合物。